Regents of the University of Colorado

Identifying the Role of SF3B1 in the Metabolic Reprograming of Myelodysplastic Syndrome Stem Cells
2024

Overview
The Vera and Joseph Dresner Foundation granted the Regents of the University of Colorado a $250,000 grant over two years for early career investigator Dr. Maria L. Amaya.

Details
Dr. Amaya with the support of her mentor, Dr. Craig Jordan, will develop effective and well-tolerated treatments for SF3B1-mutant myelodysplastic syndromes (MDS). Dr. Amaya hypothesizes that SF3B1-mutant MDS cells have unique metabolic needs that can be targeted, leading to new treatment strategies for this population.

Learn more about Regents of the University of Colorado.